Abstract
Background Plant-rich dietary patterns may protect against negative health outcomes among individuals with chronic kidney disease (CKD), although aspects of plant-based diet quality have not been studied. This study aimed to examine associations between healthful and unhealthful plant-based dietary patterns with risk of mortality among CKD patients for the first time.
Methods This prospective analysis included 4,807 UK Biobank participants with CKD at baseline. We examined associations of adherence to both the healthful plant-based diet index (hPDI) and unhealthful plant-based diet index (uPDI), calculated from repeated 24-hour dietary assessments, with risk of mortality using multivariable Cox proportional hazard regression models.
Results Over a 10-year follow-up, 675 deaths were recorded. Participants with the highest hPDI scores had a 33% lower risk of mortality [HRQ4vsQ1 (95% CI): 0.67 (0.53-0.84), ptrend = <0.001], while those with the highest uPDI scores had a 49% higher risk [1.49 (1.18-1.89), ptrend = 0.004], compared to participants with the lowest respective scores and following adjustment for other dietary and lifestyle factors. In food group-specific analyses, higher wholegrain intakes were associated with a 29% lower mortality risk, while intakes of refined grains, and sugar-sweetened beverages were associated a 28% and 31% higher risk, respectively.
Conclusions In CKD patients, a higher intake of healthy plant-based foods was associated with a lower risk of mortality, while a higher intake of unhealthy plant-based foods was associated with a higher risk. These results underscore the importance of plant food quality and support the potential role of healthy plant food consumption in the treatment and management of CKD to mitigate unfavourable outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was conducted using UK Biobank funded and sourced data (application 64426). The UK Biobank was established by the Wellcome Trust, the Medical Research Council, the UK Department of Health, and the Scottish Government. The UK Biobank has also received funding from the Welsh Assembly Government, the British Heart Foundation, and Diabetes United Kingdom, Northwest Regional Development Agency, Scottish Government. In addition, Alysha S. Thompson holds a PhD studentship of the Department for the Economy (DfE), Northern Ireland. This work was in part supported by the Co-Centre for Sustainable and Resilient Food Systems.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank data can be requested by all bona fide researchers for approved projects, including replication, through https://www.ukbiobank.ac.uk/. This research was conducted using UK Biobank funded and sourced data (application 64426).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
UK Biobank data can be requested by all bona fide researchers for approved projects, including replication, through https://www.ukbiobank.ac.uk/. This research was conducted using UK Biobank funded and sourced data (application 64426).
